Depolarization preconditioning produces cytoprotection against veratridine-induced chromaffin cell death

European Journal of Pharmacology

Volumn 553, Issue 1-3, 2006, Pages 28-38

  Orozco, Camilo ^a   García de Diego, Antonio M ^a   Arias, Esperanza ^a   Hernández Guijo, Jesús M ^a   García, Antonio G ^a,b   Villarroya, Mercedes ^a   López, Manuela G ^a  

^a AUTONOMOUS UNIVERSITY OF MADRID   (Spain)

^b HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

Chromaffin cell; Cytoprotection; Depolarization; Preconditioning; Veratridine

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CALCIUM ION; POTASSIUM CHANNEL; POTASSIUM ION; PROTEIN BCL 2; TETRYLAMMONIUM; VERATRIDINE;

ACTION POTENTIAL; ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CELL DEATH; CELL MEMBRANE DEPOLARIZATION; CELL PROTECTION; CHROMAFFIN CELL; CONTROLLED STUDY; CYTOSOL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BLOTTING, WESTERN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CALCIUM; CATTLE; CELL DEATH; CELLS, CULTURED; CHROMAFFIN CELLS; CYCLOHEXIMIDE; CYTOPROTECTION; CYTOSOL; EXTRACELLULAR SPACE; L-LACTATE DEHYDROGENASE; MEMBRANE POTENTIALS; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHLORIDE; PROTO-ONCOGENE PROTEINS C-BCL-2; TETRAETHYLAMMONIUM; VERATRIDINE;

EID: 33751159817     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.08.084     Document Type: Article

References (67)

1. Akasofu S., Kosasa T., Kimura M., and Kubota A. Protective effect of donepezil in a primary culture of rat cortical neurons exposed to oxygen-glucose deprivation. Eur. J. Pharmacol. 472 (2003) 57-63
2. Almeida R.D., Manadas B.J., Melo C.V., Gomes J.R., Mendes C.S., Graos M.M., Carvalho R.F., Carvalho A.P., and Duarte C.B. Neuroprotection by BDNF against glutamate-induced apoptotic cell death is mediated by ERK and PI3-kinase pathways. Cell Death Differ. 12 (2005) 1329-1343
3. Amy C., and Kirschner N. 22 Sodium uptake and catecholamine secretion by primary cultures of adrenal medulla cells. J. Neurochem. 39 (1982) 132-142
4. Arias E., Alés E., Gabilan N.H., Cano-Abad M.F., Villarroya M., García A.G., and López M.G. Galantamine prevents apoptosis induced by beta-amyloid and thapsigargin: involvement of nicotinic acetylcholine receptors. Neuropharmacology 46 (2004) 103-114
5. Arias E., Gallego-Sandin S., Villarroya M., Garcia A.G., and Lopez M.G. Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil and rivastigmine: role of nicotinic receptors of SH-SY5H neuroblastoma cells. J. Pharmacol. Exp. Ther. 315 (2005) 1346-1353
6. Artalejo A.R. Electrical properties of adrenal chromaffin cells. In: Hescheler J., and Scherübl H. (Eds). The Electrophysiology of Neuroendocrine Cells (1995), CRC PRESS, Boca Raton, Florida 259-299
7. + channels in bovine chromaffin cells. Pflügers Arch. 423 (1993) 97-103
8. Barry P.H., and Lynch J.W. Liquid junction potentials and small cell effects in patch-clamp analysis. J. Membr. Biol. 121 (1991) 101-117
9. Bönisch H., and Keller B. Tetrodotoxin-sensitive and -resistant effects of veratridine on the noradrenergic neurone of the rat vas deferens. Naunyn-Schmiedeberg's Arch. Pharmacol. 324 (1983) 264-270
10. Cano-Abad M.F., Villarroya M., García A.G., Gabilan N.H., and López M.G. Calcium entry through L-type calcium channels causes mitochondrial disruption and chromaffin cell death. J. Biol. Chem. 276 (2001) 39695-39704
11. Capsoni S., Giannotta S., and Cattaneo A. Nerve growth factor and galantamine ameliorate early signs of neurodegeneration in anti-nerve growth factor mice. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 12432-12437
12. Catterral W.A., and Coppersmith J. Pharmacological properties of sodium channels in cultured rat heart cells. Mol. Pharmacol. 20 (1981) 533-542
13. Choi D.W. Ischemia-induced neuronal apoptosis. Curr. Opin. Neurobiol. 6 (1996) 667-672
14. Collins F., and Lile J.D. The role of dihydropyridine-sensitive voltage-gated calcium channels in potassium-mediated neuronal survival. Brain Res. 502 (1989) 99-108
15. Colom L.V., Diaz M.E., Beers D.R., Neely A., Xie W.J., and Appel S.H. Role of potassium channels in amyloid-induced cell death. J. Neurochem. 70 (1998) 1925-1934
16. Coyle J., and Kershaw P. Galantamine, a cholinesterase inhibitor that allosterically modulates nicotinic receptors: effects on the course of Alzheimer's disease. Biol. Psychiatry 49 (2001) 289-299
17. Dallaporta B., Hirsch T., Susin S.A., Zamzami N., Larochette N., Brenner C., Marzo I., and Kroemer G. Potassium leakage during the apoptotic degradation phase. J. Immunol. 160 (1998) 5605-5615
18. 2+ in single chromaffin cells. Eur. J. Pharmacol. 306 (1996) 219-226
19. Dragunow M., Faull R.L., Lawlor P., Beilharz E.J., Singleton K., Walker E.B., and Mee E. In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes. NeuroReport 6 (1995) 1053-1057
20. Dronfield S., Egan K., Marsden C.A., and Green A.R. Comparison of donepezil-, tacrine-, rivastigmine- and metrifonate-induced central and peripheral cholinergically mediated responses in the rat. J. Psychopharmacol. 14 (2001) 275-279
21. Franklin J.L., and Johnson Jr. E.M. Suppression of programmed neuronal death by sustained elevation of cytoplasmic calcium. Trends Neurosci. 15 (1992) 501-508
22. Gallo V., Kingsbury A., Balazs R., and Jorgensen O.S. The role of depolarization in the survival and differentiation of cerebellar granule cells in culture. J. Neurosci. 7 (1987) 2203-2213
23. Galvan M., Grafe P., and Bruggencate G. Presynaptic actions of 4-aminopyridine and gamma-aminobutyric acid on rat sympathetic ganglia in vitro. Naunyn-Schmiedeberg's Arch. Pharmacol. 314 (1980) 141-147
24. García, A.G., García-de-Diego, A.M., Gandia, L., Borges, R., García-Sancho, J., in press. Calcium signalling and exocytosis in chromaffin cells. Physiol. Rev.
25. González-García C., Ceña V., Keiser H.R., and Rojas E. Catecholamine secretion induced by tetraethylammonium from cultured bovine adrenal chromaffin cells. Biochim. Biophys. Acta 1177 (1993) 99-105
26. Hamill O.P., Marty A., Neher E., Sakmann B., and Sigworth F.J. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch. 391 (1981) 85-100
27. Hardingham G.E., and Bading H. Calcium as a versatile second messenger in the control of gene expression. Microsc. Res. Tech. 46 (1999) 348-355
28. Haylett D.G., and Jenkinson D.H. In: Cook N.S. (Ed). In Potassium Channels: Structure, Classification, Function and Therapeutic Potential (1990), John Wiley and Sons 71-95
29. 2+ channels in chromaffin cells: role of mitochondria. J. Neurosci. 21 (2001) 2553-2560
30. Heurteaux C., Messier C., Destrade C., and Lazdunski M. Memory processing and apamin induced immediate early gene expression in mouse brain. Mol. Brain Res. 3 (1993) 17-22
31. Hughes Jr. F.M., and Cidlowski J.A. Potassium is a critical regulator of apoptotic enzymes in vitro and in vivo. Adv. Enzyme Regul. 39 (1999) 157-171
32. Inan S.Y., Aksu F., and Baysal F. The effects of some K(+) channel blockers on scopolamine- or electroconvulsive shock-induced amnesia in mice. Eur. J. Pharmacol. 40 (2000) 159-164
33. Jordan J., Galindo M.F., Calvo S., González-García C., and Cena V. Veratridine induces death in bovine chromaffin cells through superoxide production. Br. J. Pharmacol. 130 (2000) 1496-1504
34. Koh Y., and Cotman C.W. Programmed cell death: its possible contribution to neurotoxicity mediated by calcium channel antagonists. Brain Res. 587 (1992) 233-240
35. 2+ determine nerve growth factor dependence of sympathetic ganglion cells. Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 6421-6425
36. Kraliz D., and Singh S. Selective blockade of the delayed rectifier potassium current by tacrine in Drosophila. J. Neurobiol. 32 (1997) 1-10
37. Krieglstein K., and Unsicker K. Proteins from chromaffin granules promote survival of dorsal root ganglionic neurons: comparison with neurotrophins. Brain Res. Dev. Brain Res. 93 (1996) 10-17
38. Lachmund A., Gehrke D., Krieglstein K., and Unsicker K. Trophic factors from chromaffin granules promote survival of peripheral and central nervous system neurons. Neuroscience 62 (1994) 361-370
39. Lee J., Duan W., and Mattson M.P. Evidence that brain-derived neurotrophic factor is required for basal neurogenesis and mediates, in part, the enhancement of neurogenesis by dietary restriction in the hippocampus of adult mice. J. Neurochem. 82 (2002) 1367-1375
40. López M.G., Artalejo A.R., Garcia A.G., Neher E., and Garcia-Sancho J. Veratridine-induced oscillations of cytosolic calcium and membrane potential in bovine chromaffin cells. J. Physiol. 482 (1995) 15-27
41. Marini A.M., Jiang X., Wu X., Tian F., Zhu D., Okagaki P., and Lipsky R.H. Role of brain-derived neurotrophic factor and NF-kappa B in neuronal plasticity and survival: from genes to phenotype. Restor. Neurol. Neurosci. 22 (2004) 121-130
42. 2+ oscillations induced by veratridine. Eur. J. Pharmacol. 270 (1994) 331-339
43. + channels, on learning and memory processes. Brain Res. 551 (1991) 322-326
44. Moro M.A., López M.G., Gandía L., Michelena P., and García A.G. Separation and culture of living adrenaline- and noradrenaline-containing cells from bovine adrenal medullae. Anal. Biochem. 185 (1990) 243-248
45. Neely A., and Lingle C.J. Two components of calcium-activated potassium current in rat adrenal chromaffin cells. J. Physiol. 453 (1992) 97-131
46. Oh M.M., Power J.M., Thompson L.T., Moriearty P.L., and Disterhoft J.F. Metrifonate increases neuronal excitability in CA1 pyramidal neurons from both young and aging rabbit hippocampus. J. Neurosci. 19 (1999) 1814-1823
47. Orozco C., De Los Rios C., Arias E., Leon R., García A.G., Marco J.L., Villarroya M., and López M.G. ITH4012, a novel acetylcholinesterase inhibitor with "calcium promotor" and neuroprotective properties. J. Pharmacol. Exp. Ther. 310 (2004) 987-994
48. Pan Y., Xu X., and Wang X. Galantamine blocks delayed rectifier, but not transient outward potassium current in rat dissociated hippocampal pyramidal neurons. Neurosci. Lett. 33 (2002) 37-40
49. Pike C.J., Balazs R., and Cotman C.W. Attenuation of beta-amyloid neurotoxicity in vitro by potassium-induced depolarization. J. Neurochem. 67 (1996) 1774-1777
50. AHP in CA1 pyramidal neurons in vitro. J. Neurophysiol. 85 (2001) 319-322
51. Rae J., Cooper K., Gates P., and Watsky M. Low access resistance perforated patch recordings using amphotericin B. J. Neurosci. Methods 37 (1991) 15-26
52. Rogawski M.A. Tetrahydroaminoacridine blocks voltage-dependent ion channels in hippocampal neurons. Eur. J. Pharmacol. 142 (1987) 169-172
53. Sahakian B.J., Owen A.M., Morant N.J., Eagger S.A., Boddington S., Crayton L., Crockford H.A., Crooks M., Hill K., and Levy R. Further analysis of the cognitive effects of tetrahydroaminoacridine (THA) in Alzheimer's disease: assessment of attentional and mnemonic function using CANTAB. Psychopharmacology 110 (1993) 395-401
54. Schaller B. Ischemic preconditioning as induction of ischemic tolerance after transient ischemic attacks in human brain: its clinical relevance. Neurosci. Lett. 377 (2005) 206-211
55. Sobrado M., Roda J.M., López M.G., Egea J., and García A.G. Galantamine and memantine produce different degrees of neuroprotection in rat hippocampal slices subjected to oxygen-glucose deprivation. Neurosci. Lett. 365 (2004) 132-136
56. + channels modulate synaptic plasticity and memory encoding. J. Neurosci. 22 (2002) 10163-10171
57. Summers W.K., Majovski L.V., Marsh G.M., Tachiki K., and Kling A. Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type. N. Engl. J. Med. 315 (1986) 1241-1245
58. Takada Y., Yonezawa A., Kume T., Katsuki H., Kaneko S., Sugimoto H., and Akaike A. Nicotinic acetylcholine receptor-mediated neuroprotection by donepezil against glutamate neurotoxicity in rat cortical neurons. J. Pharmacol. Exp. Ther. 306 (2003) 772-777
59. +] inhibits death-receptor- and chemical-mediated apoptosis prior to caspase activation and cytochrome c release. Biochem. J. 357 (2001) 137-145
60. Tong J.X., Vogelbaum M.A., Drzymala R.E., and Rich K.M. Radiation-induced apoptosis in dorsal root ganglion neurons. J. Neurocytol. 26 (1997) 771-777
61. Ueda M., and Nowak Jr. T.S. Protective preconditioning by transient global ischemia in the rat: components of delayed injury progression and lasting protection distinguished by comparisons of depolarization thresholds for cell loss at long survival times. J. Cereb. Blood Flow Metab. 25 (2005) 949-958
62. Ulbricht W., and Wagner H.H. Block of potassium channels of the nodal membrane by 4-aminopyridine and its partial removal on depolarization. Pflügers Arch. 367 (1976) 77-87
63. Xia S., Lampe P.A., Deshmukh M., Yang A., Brown B.S., Rothman S.M., Johnson Jr. E.M., and Yu S.P. Multiple channel interactions explain the protection of sympathetic neurons from apoptosis induced by nerve growth factor deprivation. J. Neurosci. 22 (2002) 114-122
64. Yu S.P., Yeh C.H., Sensi S.L., Gwag B.J., Canzoniero L.M., Farhangrazi Z.S., Ying H.S., Tian M., Dugan L.L., and Choi D.W. Mediation of neuronal apoptosis by enhancement of outward potassium current. Science 278 (1997) 114-117
65. Yu S.P., Farhangrazi Z.S., Ying H.S., Yeh C.H., and Choi D.W. Enhancement of outward potassium current may participate in beta-amyloid peptide-induced cortical neuronal death. Neurobiol. Dis. 5 (1998) 81-88
66. + current in ceramide-induced caspase activation and apoptosis in cultured cortical neurons. J. Neurochem. 73 (1999) 933-941
67. Yu S.P., Canzoniero L.M., and Choi D.W. Ion homeostasis and apoptosis. Curr. Opin. Cell Biol. 13 (2001) 405-411